Literature DB >> 14521681

Nursing interventions for patients with chronic conditions.

Liv Merete Holm Frich1.   

Abstract

BACKGROUND: Maintaining independence in older people or restoring and encouraging self-management in those with chronic conditions are ways of increasing health-related quality of life and at the same time may achieve cost savings. Nurses often carry out these types of interventions in follow-up home visits. AIMS: To describe nursing interventions during home visits and their effects on people suffering from a range of chronic conditions.
METHOD: A structured descriptive review was carried out using the Medline, Embase, PsycINFO, CINAHL and Cochrane databases and the terms chronic or diabetic or arthrit* or pain and randomi* and [(nurs* and care) or (nurs* and interventions)].
FINDINGS: In older people the best outcomes are reached if the target population is 'the younger-old', or if intervention is tailored to elders who have stated health problems. The effect depends on the duration of the follow-up period, number of follow-up visits and personality of the nurse. Follow-up nursing interventions for patients with diabetes can improve psychosocial and health outcomes. Education of health providers and amount of time spent with patients seem to be important for positive outcome. A rheumatology nurse specialist seems to provide equally good clinical results as a rheumatologist and produces better patient-related outcomes. Compared with a multidisciplinary team treating patients in day care or inpatient settings, a rheumatology nurse specialist provides less patient satisfaction, but equally good clinical outcomes.
CONCLUSIONS: Patients with chronic conditions often benefited from follow-up visits by nurses. Visits should be multiple, extended over a long-term, and interventions should be individualized. The outcomes may be described as patient satisfaction, good clinical outcomes and cost savings. Future randomized controlled trials should describe nurses' interventions and educational background to enable replication. Randomized controlled trials using the Health Technology Assessment method would permit comparison between studies and be a good foundation for future decision-making.

Entities:  

Mesh:

Year:  2003        PMID: 14521681     DOI: 10.1046/j.1365-2648.2003.02779.x

Source DB:  PubMed          Journal:  J Adv Nurs        ISSN: 0309-2402            Impact factor:   3.187


  5 in total

1.  Thoughts and perceptions of ankylosing spondylitis patients with regard to TNF inhibitors.

Authors:  Fatma Ilknur Cinar; Muhammet Cinar; Sedat Yilmaz; Ismail Simsek; Hakan Erdem; Salih Pay
Journal:  Rheumatol Int       Date:  2013-12-29       Impact factor: 2.631

2.  Nurse- and peer-led self-management programme for patients with an implantable cardioverter defibrillator; a feasibility study.

Authors:  Esther S T F Smeulders; Jolanda C M van Haastregt; Barbara K Dijkman-Domanska; Elisabeth F M van Hoef; Jacques Th M van Eijk; Gertrudis I J M Kempen
Journal:  BMC Nurs       Date:  2007-09-19

3.  A randomized controlled trial of a nurse-led case management programme for hospital-discharged older adults with co-morbidities.

Authors:  Susan Ka Yee Chow; Frances Kam Yuet Wong
Journal:  J Adv Nurs       Date:  2014-03-12       Impact factor: 3.187

Review 4.  Chronic disease management in Sub-Saharan Africa: whose business is it?

Authors:  Alexander Bischoff; Tetanye Ekoe; Nicolas Perone; Slim Slama; Louis Loutan
Journal:  Int J Environ Res Public Health       Date:  2009-08-14       Impact factor: 3.390

5.  Evaluation design of Urban Health Centres Europe (UHCE): preventive integrated health and social care for community-dwelling older persons in five European cities.

Authors:  Carmen B Franse; Antonius J J Voorham; Rob van Staveren; Elin Koppelaar; Rens Martijn; Elisa Valía-Cotanda; Tamara Alhambra-Borrás; Tasos Rentoumis; Lovorka Bilajac; Vanja Vasiljev Marchesi; Tomislav Rukavina; Arpana Verma; Greg Williams; Gary Clough; Jorge Garcés-Ferrer; Francesco Mattace Raso; Hein Raat
Journal:  BMC Geriatr       Date:  2017-09-11       Impact factor: 3.921

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.